Continuous Glucose Monitoring Device Market
Description
Continuous Glucose Monitoring Device Market
Continuous Glucose Monitoring Device Market: Global Industry Analysis 2018-2022 and Opportunity Assessment 2023-2033
A recent market study published by FMI on Continuous Glucose Monitoring Device offers a global industry analysis for 2018-2022 and opportunity assessment for 2023-2033. The study offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters, the growth prospects of the market are obtained with maximum precision.
Market Segmentation
By Component:
- Transmitters
- Sensors
- Receivers
- Hospitals
- Home Care
- Other End-uses
- North America
- Europe
- Asia Pacific
- Latin America
- MEA
Executive Summary
The executive summary of the Continuous Glucose Monitoring Device Market includes the global market outlook, demand side trends, supply side trends and also include FMI analysis and recommendations of Vehicle Radar Test System.
Chapter 01 - Market Overview
Readers can find the detailed segmentation and definition of the Continuous Glucose Monitoring Device Market in this chapter, which will help to understand basic information about Vehicle Radar Test System. This section also highlights the market scope, taxonomy and limitations which help the reader understand the market coverage of Continuous Glucose Monitoring Device Market report.
Chapter 02 - Market Background
This chapter includes detailed analysis of the By Component processing methods overview, consumer buying patterns & tendencies and policy developments and regulatory scenario. It also includes in depth analysis of macro-economic factors and covers topics like global GDP growth outlook, global industry value added, personal consumption, expenditures, modern trade penetration and consumer price indices. The chapter also covers forecast factors - relevance & impact, value chain analysis and market dynamics (drivers, restraints and opportunities) to better understand the market.
Chapter 03 - Global Continuous Glucose Monitoring Device Market Demand Analysis 2018-2022 and Forecast, 2023-2033
The chapter include historical market value (US$ 4.9 Billion) analysis (2018-2022) and current and future market value (US$ 5.5 Billion) and volume (11.9%) projections (2023-2033). The projections are based on the Y-O-Y growth trend analysis and absolute $ opportunity analysis country of operation.
Chapter 04 - Global Continuous Glucose Monitoring Device Market - Pricing Analysis
Based on By Component, the pricing analysis chapter include Regional pricing analysis (USD/MT), global average pricing analysis benchmark, and key factors impacting the pricing.
Chapter 05 - Global Continuous Glucose Monitoring Device Market Analysis 2018-2022 and Forecast 2023-2033, By Component
Based on By Component, Continuous Glucose Monitoring Device Market is segmented into Transmitters, Sensors, Receivers. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Component.
Chapter 06 - Global Continuous Glucose Monitoring Device Market Analysis 2018-2022 and Forecast 2023-2033, By End-Use
Based on By End-Use, Continuous Glucose Monitoring Device Market is segmented into Hospitals, Home Care, Other End-uses. This section also offers market attractiveness analysis based on By End-Use. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By End-Use.
Chapter 07 - Continuous Glucose Monitoring Device Market Analysis 2018-2022 and Forecast 2023-2033, By Region
Based on By Region, Continuous Glucose Monitoring Device Market is segmented into North America, Latin America, Europe, East Asia, South Asia, Oceania and MEA. This section also offers market attractiveness analysis based on By Region. Readers can also find value forecast and Y-o-Y growth comparison for all above mentioned By Region.
Chapter 08 - North America Continuous Glucose Monitoring Device Market Analysis 2018-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of the Vehicle Radar Test System in the North American region, along with a country-wise assessment that includes the US and Canada. Readers can also find regional trends, regulations, and market growth based on different segment and countries in the North America region.
Chapter 09 - Latin America Continuous Glucose Monitoring Device Market Analysis 2018-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the Latin America region, along with a country-wise assessment that includes the Brazil, Mexico, Chile, Argentina, Peru and Rest of Latin America. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Continuous Glucose Monitoring Device Market in the Latin America region.
Chapter 10 - Europe Continuous Glucose Monitoring Device Market Analysis 2018-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the European region, along with a country-wise assessment that includes the Germany, Italy, France, U.K., Spain, Russia, Nordic, Benelux and Rest of Europe. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Continuous Glucose Monitoring Device Market in the regional market.
Chapter 11 - East Asia Continuous Glucose Monitoring Device Market Analysis 2018-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the East Asia region, along with a country-wise assessment that includes the China, Japan, and South Korea. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Continuous Glucose Monitoring Device Market in the regional market.
Chapter 12 - South Asia Continuous Glucose Monitoring Device Market Analysis 2018-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the South Asia region, along with a country-wise assessment that includes the India, Indonesia, Malaysia, Thailand, and Rest of South Asia. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Continuous Glucose Monitoring Device Market in the regional market.
Chapter 13 - Middle East and Africa Continuous Glucose Monitoring Device Market Analysis 2018-2022 and Forecast 2023-2033
This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the MEA region, along with a country-wise assessment that includes the GCC Countries, South Africa, North Africa, Turkey and Rest of MEA. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Continuous Glucose Monitoring Device Market in the regional market.
Chapter 14 - Key Countries Continuous Glucose Monitoring Device Market Analysis 2018-2022 and Forecast 2023-2033
This chapter offers insights into how the Continuous Glucose Monitoring Device Market is expected to grow in major countries globally.
Chapter 15 - Market Structure Analysis- Global Assessment
This chapter includes company dashboard, industry structure analysis by tier of companies, 2022E, company share analysis of top players, 2022E, and competition benchmarking- matrix.
Chapter 16 - Competition Deep Dive (Tentative List)
This chapter includes company overview, By Component portfolio of companies, profitability by market segments, sales footprint, SWOT analysis and strategy overview of the companies being studied in the report. Some of the market players featured in the report are A. Menarini Diagnostics, Echo Therapeutics, Inc., Abbott Laboratories, Bayer AG, Dexcom, Inc., F. Hoffmann-La Roche Ltd., GE Healthcare, GlySens Incorporated, Insulet Corporation, Johnson & Johnson, LifeScan, Medtronic plc, Medtrum Technologies, Inc., Microchip Technology Inc., Micron Technology Inc., Nemaura Medical, Inc., Novo Nordisk, NXP Semiconductors, Qualcomm, Roche Diagnostics, Senseonics Holdings, Inc., STMicroelectronics, Tandem Diabetes Care.
Chapter 17 - Assumptions and Acronyms
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the Vehicle Radar Test System report.
Chapter 18 - Research Methodology
This chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on Continuous Glucose Monitoring Device Market.
Table of Contents
250 Pages
- 1. Executive Summary | Continuous Glucose Monitoring Device Market
- 1.1. Global Market Outlook
- 1.2. Summary of Statistics
- 1.3. Key Market Characteristics & Attributes
- 1.4. Analysis and Recommendations
- 2. Market Overview
- 2.1. Market Coverage / Taxonomy
- 2.2. Market Definition / Scope / Limitations
- 3. Market Risks and Trends Assessment
- 3.1. Risk Assessment
- 3.1.1. COVID-19 Crisis and Impact on Demand
- 3.1.2. COVID-19 Impact Benchmark with Previous Crisis
- 3.1.3. Impact on Market Value (US$ Billion)
- 3.1.4. Assessment by Key Countries
- 3.1.5. Assessment by Key Market Segments
- 3.1.6. Action Points and Recommendation for Suppliers
- 3.2. Key Trends Impacting the Market
- 3.3. Formulation and Product Development Trends
- 4. Market Background and Foundation Data Points
- 4.1. Global Market (US$ Billion)
- 4.2. Market Opportunity Assessment (US$ Billion)
- 4.2.1. Total Available Market
- 4.2.2. Serviceable Addressable Market
- 4.2.3. Serviceable Obtainable Market
- 4.3. Market Scenario Forecast
- 4.3.1. Demand in optimistic Scenario
- 4.3.2. Demand in Likely Scenario
- 4.3.3. Demand in Conservative Scenario
- 4.4. Investment Feasibility Analysis
- 4.4.1. Investment in Established Markets
- 4.4.1.1. In Short Term
- 4.4.1.2. In Long Term
- 4.4.2. Investment in Emerging Markets
- 4.4.2.1. In Short Term
- 4.4.2.2. In Long Term
- 4.5. Forecast Factors - Relevance & Impact
- 4.5.1. Top Companies Historical Growth
- 4.5.2. Global Market Growth
- 4.5.3. Adoption Rate, By Country
- 4.6. Market Dynamics
- 4.6.1. Market Driving Factors and Impact Assessment
- 4.6.2. Prominent Market Challenges and Impact Assessment
- 4.6.3. Market Opportunities
- 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
- 5. Key Success Factors
- 5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
- 5.2. Banking on with Segments High Incremental Opportunity
- 5.3. Peer Benchmarking
- 6. Global Market Demand Analysis 2018 to 2022 and Forecast, 2023 to 2033
- 6.1. Historical Market Analysis, 2018 to 2022
- 6.2. Current and Future Market Projections, 2023 to 2033
- 6.3. Y-o-Y Growth Trend Analysis
- 7. Global Market Value Analysis 2018 to 2022 and Forecast, 2023 to 2033
- 7.1. Historical Market Value (US$ Billion) Analysis, 2018 to 2022
- 7.2. Current and Future Market Value (US$ Billion) Projections, 2023 to 2033
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis
- 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Component
- 8.1. Introduction / Key Findings
- 8.2. Historical Market Size (US$ Billion) Analysis By Component, 2018 to 2022
- 8.3. Current and Future Market Size (US$ Billion) Analysis and Forecast By Component, 2023 to 2033
- 8.3.1. Transmitters
- 8.3.2. Sensors
- 8.3.3. Recievers
- 8.4. Market Attractiveness Analysis By Component
- 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-use
- 9.1. Introduction / Key Findings
- 9.2. Historical Market Size (US$ Billion) Analysis By End-use, 2018 to 2022
- 9.3. Current and Future Market Size (US$ Billion) Analysis and Forecast By End-use, 2023 to 2033
- 9.3.1. Hospitals
- 9.3.2. Home care
- 9.3.3. Other end-uses
- 9.4. Market Attractiveness Analysis By End-use
- 10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
- 10.1. Introduction
- 10.2. Historical Market Size (US$ Billion) Analysis By Region, 2018 to 2022
- 10.3. Current Market Size (US$ Billion) & Analysis and Forecast By Region, 2023 to 2033
- 10.3.1. North America
- 10.3.2. Latin America
- 10.3.3. Europe
- 10.3.4. Asia Pacific
- 10.3.5. Middle East and Africa (MEA)
- 10.4. Market Attractiveness Analysis By Region
- 11. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 11.1. Introduction
- 11.2. Pricing Analysis
- 11.3. Historical Market Value (US$ Billion) Trend Analysis By Market Taxonomy, 2018 to 2022
- 11.4. Market Value (US$ Billion) & Forecast By Market Taxonomy, 2023 to 2033
- 11.4.1. By Country
- 11.4.1.1. USA
- 11.4.1.2. Canada
- 11.4.1.3. Rest of North America
- 11.4.2. By Component
- 11.4.3. By End-use
- 11.5. Market Attractiveness Analysis
- 11.5.1. By Country
- 11.5.2. By Component
- 11.5.3. By End-use
- 12. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 12.1. Introduction
- 12.2. Pricing Analysis
- 12.3. Historical Market Value (US$ Billion) Trend Analysis By Market Taxonomy, 2018 to 2022
- 12.4. Market Value (US$ Billion) & Forecast By Market Taxonomy, 2023 to 2033
- 12.4.1. By Country
- 12.4.1.1. Brazil
- 12.4.1.2. Argentina
- 12.4.1.3. Rest of Latin America
- 12.4.2. By Component
- 12.4.3. By End-use
- 12.5. Market Attractiveness Analysis
- 12.5.1. By Country
- 12.5.2. By Component
- 12.5.3. By End-use
- 13. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 13.1. Introduction
- 13.2. Pricing Analysis
- 13.3. Historical Market Value (US$ Billion) Trend Analysis By Market Taxonomy, 2018 to 2022
- 13.4. Market Value (US$ Billion) & Forecast By Market Taxonomy, 2023 to 2033
- 13.4.1. By Country
- 13.4.1.1. Germany
- 13.4.1.2. France
- 13.4.1.3. United kingdom
- 13.4.1.4. Italy
- 13.4.1.5. Spain
- 13.4.1.6. Netherlands
- 13.4.1.7. Rest of Europe
- 13.4.2. By Component
- 13.4.3. By End-use
- 13.5. Market Attractiveness Analysis
- 13.5.1. By Country
- 13.5.2. By Component
- 13.5.3. By End-use
- 14. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 14.1. Introduction
- 14.2. Pricing Analysis
- 14.3. Historical Market Value (US$ Billion) Trend Analysis By Market Taxonomy, 2018 to 2022
- 14.4. Market Value (US$ Billion) & Forecast By Market Taxonomy, 2023 to 2033
- 14.4.1. By Country
- 14.4.1.1. China
- 14.4.1.2. Japan
- 14.4.1.3. South Korea
- 14.4.1.4. Rest of Asia Pacific
- 14.4.2. By Component
- 14.4.3. By End-use
- 14.5. Market Attractiveness Analysis
- 14.5.1. By Country
- 14.5.2. By Component
- 14.5.3. By End-use
- 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 15.1. Introduction
- 15.2. Pricing Analysis
- 15.3. Historical Market Value (US$ Billion) Trend Analysis By Market Taxonomy, 2018 to 2022
- 15.4. Market Value (US$ Billion) & Forecast By Market Taxonomy, 2023 to 2033
- 15.4.1. By Country
- 15.4.1.1. Saudi Arabia
- 15.4.1.2. South Africa
- 15.4.1.3. UAE
- 15.4.1.4. Rest of Middle East and Africa
- 15.4.2. By Component
- 15.4.3. By End-use
- 15.5. Market Attractiveness Analysis
- 15.5.1. By Country
- 15.5.2. By Component
- 15.5.3. By End-use
- 16. Key Countries Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 16.1. Introduction
- 16.1.1. Market Value Proportion Analysis, By Key Countries
- 16.1.2. Global Vs. Country Growth Comparison
- 16.2. US Market Analysis
- 16.2.1. Value Proportion Analysis by Market Taxonomy
- 16.2.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
- 16.2.2.1. By Component
- 16.2.2.2. By End-use
- 16.3. Canada Market Analysis
- 16.3.1. Value Proportion Analysis by Market Taxonomy
- 16.3.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
- 16.3.2.1. By Component
- 16.3.2.2. By End-use
- 16.4. Argentina Market Analysis
- 16.4.1. Value Proportion Analysis by Market Taxonomy
- 16.4.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
- 16.4.2.1. By Component
- 16.4.2.2. By End-use
- 16.5. Brazil Market Analysis
- 16.5.1. Value Proportion Analysis by Market Taxonomy
- 16.5.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
- 16.5.2.1. By Component
- 16.5.2.2. By End-use
- 16.6. Germany Market Analysis
- 16.6.1. Value Proportion Analysis by Market Taxonomy
- 16.6.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
- 16.6.2.1. By Component
- 16.6.2.2. By End-use
- 16.7. France Market Analysis
- 16.7.1. Value Proportion Analysis by Market Taxonomy
- 16.7.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
- 16.7.2.1. By Component
- 16.7.2.2. By End-use
- 16.8. Italy Market Analysis
- 16.8.1. Value Proportion Analysis by Market Taxonomy
- 16.8.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
- 16.8.2.1. By Component
- 16.8.2.2. By End-use
- 16.9. Spain Market Analysis
- 16.9.1. Value Proportion Analysis by Market Taxonomy
- 16.9.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
- 16.9.2.1. By Component
- 16.9.2.2. By End-use
- 16.10. UK Market Analysis
- 16.10.1. Value Proportion Analysis by Market Taxonomy
- 16.10.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
- 16.10.2.1. By Component
- 16.10.2.2. By End-use
- 16.11. Netherlands Market Analysis
- 16.11.1. Value Proportion Analysis by Market Taxonomy
- 16.11.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
- 16.11.2.1. By Component
- 16.11.2.2. By End-use
- 16.12. China Market Analysis
- 16.12.1. Value Proportion Analysis by Market Taxonomy
- 16.12.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
- 16.12.2.1. By Component
- 16.12.2.2. By End-use
- 16.13. Japan Market Analysis
- 16.13.1. Value Proportion Analysis by Market Taxonomy
- 16.13.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
- 16.13.2.1. By Component
- 16.13.2.2. By End-use
- 16.14. South Korea Market Analysis
- 16.14.1. Value Proportion Analysis by Market Taxonomy
- 16.14.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
- 16.14.2.1. By Component
- 16.14.2.2. By End-use
- 16.15. Saudi Arabia Market Analysis
- 16.15.1. Value Proportion Analysis by Market Taxonomy
- 16.15.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
- 16.15.2.1. By Component
- 16.15.2.2. By End-use
- 16.16. South Africa Market Analysis
- 16.16.1. Value Proportion Analysis by Market Taxonomy
- 16.16.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
- 16.16.2.1. By Component
- 16.16.2.2. By End-use
- 16.17. UAE Market Analysis
- 16.17.1. Value Proportion Analysis by Market Taxonomy
- 16.17.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
- 16.17.2.1. By Component
- 16.17.2.2. By End-use
- 16.17.3. Competition Landscape and Player Concentration in the Country
- 17. Market Structure Analysis
- 17.1. Market Analysis by Tier of Companies
- 17.2. Market Concentration
- 17.3. Market Share Analysis of Top Players
- 17.4. Market Presence Analysis
- 17.4.1. By Regional footprint of Players
- 17.4.2. Product footprint by Players
- 18. Competition Analysis
- 18.1. Competition Dashboard
- 18.2. Competition Benchmarking
- 18.3. Competition Deep Dive
- 18.3.1. A. Menarini Diagnostics
- 18.3.1.1. Overview
- 18.3.1.2. Product Portfolio
- 18.3.1.3. Sales Footprint
- 18.3.1.4. Strategy Overview
- 18.3.2. Echo Therapeutics, Inc.
- 18.3.2.1. Overview
- 18.3.2.2. Product Portfolio
- 18.3.2.3. Sales Footprint
- 18.3.2.4. Strategy Overview
- 18.3.3. Abbott Laboratories
- 18.3.3.1. Overview
- 18.3.3.2. Product Portfolio
- 18.3.3.3. Sales Footprint
- 18.3.3.4. Strategy Overview
- 18.3.4. Bayer AG
- 18.3.4.1. Overview
- 18.3.4.2. Product Portfolio
- 18.3.4.3. Sales Footprint
- 18.3.4.4. Strategy Overview
- 18.3.5. Dexcom, Inc.
- 18.3.5.1. Overview
- 18.3.5.2. Product Portfolio
- 18.3.5.3. Sales Footprint
- 18.3.5.4. Strategy Overview
- 18.3.6. F. Hoffmann-La Roche Ltd.
- 18.3.6.1. Overview
- 18.3.6.2. Product Portfolio
- 18.3.6.3. Sales Footprint
- 18.3.6.4. Strategy Overview
- 18.3.7. GE Healthcare
- 18.3.7.1. Overview
- 18.3.7.2. Product Portfolio
- 18.3.7.3. Sales Footprint
- 18.3.7.4. Strategy Overview
- 18.3.8. Glycens
- 18.3.8.1. Overview
- 18.3.8.2. Product Portfolio
- 18.3.8.3. Sales Footprint
- 18.3.8.4. Strategy Overview
- 18.3.9. Insulet Corporation
- 18.3.9.1. Overview
- 18.3.9.2. Product Portfolio
- 18.3.9.3. Sales Footprint
- 18.3.9.4. Strategy Overview
- 18.3.10. Johnson & Johnson
- 18.3.10.1. Overview
- 18.3.10.2. Product Portfolio
- 18.3.10.3. Sales Footprint
- 18.3.10.4. Strategy Overview
- 18.3.11. LifeScan
- 18.3.11.1. Overview
- 18.3.11.2. Product Portfolio
- 18.3.11.3. Sales Footprint
- 18.3.11.4. Strategy Overview
- 18.3.12. Medtronic plc
- 18.3.12.1. Overview
- 18.3.12.2. Product Portfolio
- 18.3.12.3. Sales Footprint
- 18.3.12.4. Strategy Overview
- 18.3.13. Medtrum Technologies, Inc.
- 18.3.13.1. Overview
- 18.3.13.2. Product Portfolio
- 18.3.13.3. Sales Footprint
- 18.3.13.4. Strategy Overview
- 18.3.14. Microchip Technology Inc.
- 18.3.14.1. Overview
- 18.3.14.2. Product Portfolio
- 18.3.14.3. Sales Footprint
- 18.3.14.4. Strategy Overview
- 18.3.15. Micron Technology Inc.
- 18.3.15.1. Overview
- 18.3.15.2. Product Portfolio
- 18.3.15.3. Sales Footprint
- 18.3.15.4. Strategy Overview
- 18.3.16. Nemaura Medical, Inc.
- 18.3.16.1. Overview
- 18.3.16.2. Product Portfolio
- 18.3.16.3. Sales Footprint
- 18.3.16.4. Strategy Overview
- 18.3.17. Novo Nordisk
- 18.3.17.1. Overview
- 18.3.17.2. Product Portfolio
- 18.3.17.3. Sales Footprint
- 18.3.17.4. Strategy Overview
- 18.3.18. NXP Semiconductors
- 18.3.18.1. Overview
- 18.3.18.2. Product Portfolio
- 18.3.18.3. Sales Footprint
- 18.3.18.4. Strategy Overview
- 18.3.19. Qualcomm
- 18.3.19.1. Overview
- 18.3.19.2. Product Portfolio
- 18.3.19.3. Sales Footprint
- 18.3.19.4. Strategy Overview
- 18.3.20. Roche Diagnostics
- 18.3.20.1. Overview
- 18.3.20.2. Product Portfolio
- 18.3.20.3. Sales Footprint
- 18.3.20.4. Strategy Overview
- 18.3.21. Senseonics Holdings, Inc.
- 18.3.21.1. Overview
- 18.3.21.2. Product Portfolio
- 18.3.21.3. Sales Footprint
- 18.3.21.4. Strategy Overview
- 18.3.22. STMicroelectronics
- 18.3.22.1. Overview
- 18.3.22.2. Product Portfolio
- 18.3.22.3. Sales Footprint
- 18.3.22.4. Strategy Overview
- 18.3.23. Tandem Diabetes Care
- 18.3.23.1. Overview
- 18.3.23.2. Product Portfolio
- 18.3.23.3. Sales Footprint
- 18.3.23.4. Strategy Overview
- 19. Assumptions and Acronyms Used
- 20. Research Methodology
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
